Point72 Hong Kong LTD Guardant Health, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $448,899 - $889,418	27,934 New	27,934 $806,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $382,893 - $523,418	17,743 New	17,743 $479,000
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $1.46 Million - $1.95 Million	-14,783 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $1.62 Million - $2.45 Million	14,783 New	14,783 $1.84 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $2,002 - $3,529	-32 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $2,046 - $2,915	32 New	32 $3,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.